ASH 2017: IMWG Conference Series

(1:2:47)

Mikkael A. Sekeres, MD, MS: Highlights of the 2017 ASH Annual Meeting

(3:59)

Progress still being made in MM: highlights of ASH 2017

(50)

Meet the 2017 ASH President

(2:9)

ASH 2017 President’s meeting highlights

(3:57)

PV Reporter interviews Dr. Michael Grunwald at ASH 2017

(12:)

ECHELON-1 trial data from ASH 2017: controversies and clinical translation

(3:9)

MPNs update from ASH 2017

(5:29)

Welcome From 2017 ASH President

(2:12)

ASH 2017 top picks: Phase III trials, antibody-drug conjugates and CAR T-cells

(1:18)

Ash - Emotions

(4:2)

A novel BTK inhibitor BGB-3111: new data presented at ASH 2017

(2:45)

AML highlights from ASH 2017

(3:8)

Advancements at ASH 2017 that are directly relevant to patients

(2:18)

Multiple myeloma highlights at ASH 2017

(1:34)

CAR T-cells for lymphoma: data from ASH 2017

(2:13)

Prof. Nathan Fowler | ASH 2017 | Highlights of ASH 2017 in Follicular Lymphoma

(4:53)

Prof. Sonali Smith | ASH 2017 | Highlights of ASH 2017 in aggressive NHL

(3:54)

Key abstracts being presented at ASH 2017

(5:37)

ASH 2017 - Shaji Kumar Interview

(4:19)